Bed bug histamines persistent in infested areas

New research suggests bed bugs are a medically important threat


New research suggests bed bugs are a medically important threat, according to an article on the Infection Control Today website.

A North Carolina State University study shows that histamine levels are substantially higher in areas bed-bug-infested areas and that these histamine levels persist for months after the bed bugs have been eliminated.

“Histamine levels in bed bug-infested homes were at least 20 times higher than histamine levels in homes without bed bugs,” the study's author said. “And these levels didn’t decrease much three months after treating the infested homes with heat and insecticides.”

Bed bugs naturally give off high levels of histamine in their feces. They use histamine as a marker of a good place to aggregate. 

Read the article.

 

 



February 16, 2018


Topic Area: Infection Control


Recent Posts

How Architects Shape the Future of Healthcare Facilities

Healthcare architecture is more than just designing and building hospitals.


UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital

The partners plan to break ground together on the new NC Children’s campus by 2027.


Sarasota Memorial Hospital Plans to Build New Facility in North Port

The six-story, 100-bed hospital is slated to open in fall of 2028.


CMMS, Data and the Path to Compliance

Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.


Healthcare is a Major Ransomware Target

Healthcare is the third-most-targeted sector, according to the report.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.